share_log
Breakings ·  Jun 28 20:11
NRX Pharmaceuticals Inc: Nda for NRX-100 in Advanced Preparation for Submission in 2024, Potential Revenue in 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment